| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507526A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/17/2005 | WO2005014602A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005014560A1 A process for the preparation of phenyltetrazole derivatives |
| 02/17/2005 | WO2005014525A2 Bi-aryl compound having immunosuppressive activity |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038249 metal complexes used as prodrugs that may be activated under hypoxic conditions by enzymes or by radiotherapy for treatment of cancer |
| 02/17/2005 | CA2534892A1 A process for the preparation of phenyltetrazole derivatives |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | CA2532175A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 02/16/2005 | EP1506040A2 Selective inos inhibitors for the treatment of respiratory diseases and conditions |
| 02/16/2005 | EP1505972A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/10/2005 | WO2005012267A1 Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same |
| 02/10/2005 | WO2005011646A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 02/10/2005 | US20050033106 Synthesis of tris N-alkylated 1,4,7,10-tetraazacyclododecanes |
| 02/10/2005 | CA2534451A1 Angiotensin ii receptor blocker derivatives |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | US20050027008 Having phenyl or naphthyl moeity; Secondary carbocyclic amides such as 2-(4-(2-naphthyloxy)-benzamido)benzoic acid methyl ester; cytotoxic activity against human cancer cells |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020680 Hydroxyfattysulfonic acid analogs |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/25/2005 | CA2102461C Process for the production of metal complexes of n-.beta- hydroxyalkyl-tri-n-carboxyalkyl-1,4,7,10- tetraazacyclododecane and n-.beta.-hydroxyalkyl-tri-n- carboxyalkyl-1,4,8,11 tetraazacyclotetradecane derivatives |
| 01/20/2005 | WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 01/20/2005 | US20050014804 Tetrazole and oxadiazolone substituted beta-amino acid derivatives |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/13/2005 | WO2005003105A1 Synthesis of tris n-alkylated 1,4,7,10-tetraazacyclododecanes |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050010053 By-product inhibition; synthesis from pure valine, or methyl ester thereof; hypotensive agents |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009704 Substituted aryl ketones |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | CN1563023A 3, 6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and accessory ingredient of transition metal, preparation and application |
| 01/12/2005 | CN1562984A Compound of hydrosulfuryl-substitution azacycle |
| 01/12/2005 | CN1562983A Method for preparing sulfhydyl-(m-benzamido) phenyl tetrazole |
| 01/12/2005 | CN1562982A Method for producing sulf-5 position substituted tetrazole |
| 01/12/2005 | CN1562981A Method for fabricating halogenation linear chain paraffin tetrazole |
| 01/12/2005 | CN1562980A Method for producing 1-ethoxyl-5-mercapto-tetrazole |
| 01/06/2005 | WO2005000823A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | US20050004192 Inhibiting virus's own RNA-dependent RNA polymerase, NS5B |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/06/2005 | CA2529332A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/04/2005 | US6838557 Process for making a chelating agent for labeling biomolecules using preformed active esters |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267024 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides |
| 12/30/2004 | US20040265236 Trimeric macrocyclic substituted benzene derivatives |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1285917B1 Process for producing carbostyril derivative |
| 12/29/2004 | EP1123274B1 Substituted phenyl derivatives, their preparation and use |
| 12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
| 12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
| 12/23/2004 | WO2004111018A1 A novel process for preparation of valsartan |
| 12/23/2004 | WO2004111017A1 Diphenylurea derivatives and their use as chloride channel blockers |
| 12/23/2004 | WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | US20040258618 Magnetic resonance imaging of substrate molecule different from water; shortening relaxation times; in vivo mapping citrate; tumors |
| 12/23/2004 | CA2529806A1 Diphenylurea derivatives and their use as chloride channel blockers |
| 12/22/2004 | EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases |
| 12/22/2004 | CN1556707A Ophthalmologic treatment methods using selective iNOS inhibitors |
| 12/22/2004 | CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors |
| 12/15/2004 | EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 12/14/2004 | CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis |
| 12/09/2004 | WO2004106280A1 CaSR ANTAGONIST |
| 12/09/2004 | US20040248857 treatment of gram positive, gram negative and antibiotic resistant infections; 1,11-dioxo-2-naphthacenecarboxamide derivatives |
| 12/09/2004 | US20040248850 Compounds for the treatment of HIV infection |